Ching-Hung Lin

9PUBLICATIONS
66CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyHaematological tumoursDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Mar 05, 2025
Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study.

Chiao Lo, Dwan-Ying Chang, Yen-Shen Lu

|Jul 05, 2024
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.

Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu

|Sep 22, 2023
Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis.

Shang-Hsuan Peng, Ching-Hung Lin, I-Chun Chen

|Aug 08, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel.

Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho

|Dec 14, 2022
Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women.

Ching-Hung Lin, Muhammad Zahid, Wen-Hung Kuo

Pageof 2

Frequent Collaborators

5 joint publications

Yen-Shen Lu

3 joint publications

I-Chun Chen

2 joint publications

Ching-Hsuan Chen

2 joint publications

Wei-Wu Chen